SCHEMBL8229849

SCHEMBL8229849

COC(=O)CSc1nc2ccccc2n1C

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
LMNA P02545 3/20 0.63
NPSR1 Q6W5P4 2/20 0.59
KMT2A Q03164 2/20 0.59
PKM P14618 1/20 0.59
HSD17B10 Q99714 2/20 0.58
HPGD P15428 1/20 0.58
ALOX15 P16050 1/20 0.58
MAPK1 P28482 1/20 0.58
RXFP1 Q9HBX9 1/20 0.58
GPR55 Q9Y2T6 1/20 0.58
NPC1 O15118 1/20 0.57
PSMD14 O00487 1/20 0.56
GAA P10253 1/20 0.56
MAPT P10636 3/20 0.56
POLB P06746 1/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19403443 0.86 PSMD14 (0.75) ALDH1A1LMNANPSR1KMT2AHPGD
SCHEMBL4476411 0.84 ALDH1A1 (0.71) ALDH1A1LMNANPSR1KMT2APKM
SCHEMBL9725963 0.84 ALDH1A1 (0.67) ALDH1A1LMNANPSR1KMT2APKM
SCHEMBL4791742 0.83 KMT2A (0.67) ALDH1A1LMNANPSR1KMT2APKM
Hydrochloric Acid SCHEMBL3519020 0.83 ALDH1A1 (0.69) ALDH1A1LMNANPSR1KMT2APKM
SCHEMBL20545506 0.82 PTGDR2 (0.58) ALDH1A1LMNANPSR1KMT2APKM
SCHEMBL4295684 0.80 L3MBTL1 (0.69) ALDH1A1NPSR1HSD17B10HPGDNPC1
SCHEMBL20388066 0.79 ALOX15 (0.48) ALDH1A1LMNANPSR1KMT2AHSD17B10
SCHEMBL6202497 0.76 ALDH1A1 (0.58) ALDH1A1LMNANPSR1KMT2APKM
SCHEMBL12500188 0.76 POLB (0.69) ALDH1A1LMNAHSD17B10NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017164813-A1 ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2017-09-28 WO disclosed
US-20100029736-A1 2-SUBSTITUTED PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2010-02-04 US disclosed
US-20100029736-A1 2-SUBSTITUTED PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2010-02-04 US disclosed
WO-2008008551-A2 2-SUBSTITUTED PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029736-A1 2-SUBSTITUTED PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, NPSR1 ALDH1A1 3827/4885LMNA 2734/4885NPSR1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.